Xtrackers MSCI Genomic Healthcare Innovation ETF 1C
28,53
EUR
+0,24
EUR
+0,83
%
Werbung
Werbung
Xtrackers MSCI Genomic Healthcare Innovation ETF 1C Kurs - 1 Jahr
Baader Bank Berlin gettex Düsseldorf Lang & Schwarz London München Stuttgart SIX SX USD SIX SX Tradegate XETRA Quotrix
Baader Bank
Berlin
gettex
Düsseldorf
Lang & Schwarz
London
München
Stuttgart
SIX SX USD
SIX SX
Tradegate
XETRA
Quotrix
| Emittent | DWS Investment (ETF) |
| Auflagedatum | 12.07.2022 |
| Kategorie | Aktien |
| Fondswährung | USD |
| Benchmark | |
| Ausschüttungsart | Thesaurierend |
| Total Expense Ratio (TER) | 0,30 % |
| Fondsgröße | 3.531.809,97 |
| Replikationsart | Physisch vollständig |
| Morningstar Rating | - |
Anlageziel Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc
So investiert der Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc: The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of the shares of large, medium, and small-capitalisation companies that derive, or are expected to derive, significant revenues from technological innovation in the genomic healthcare sector and which promote, among other characteristics, environmental and social characteristics.
Der Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: DBX0R2
| 3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2025 | |
|---|---|---|---|---|---|---|
| Performance | - | - | - | - | - | - |
| Outperformance ggü. Kategorie | - | - | - | - | - | - |
| Max Verlust | - | - | -9,82 % | - | - | - |
| Kurs | - | - | - | - | - | - |
| Hoch | - | - | - | - | - | - |
| Tief | - | - | - | - | - | - |
Kennzahlen ISIN: IE000KD0BZ68
| Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
|---|---|---|---|---|
| Volatilität | 17,06 % | |||
| Sharpe Ratio | +0,17 |
Werbung
Werbung
Zusammensetzung WKN: DBX0R2
Größte Positionen ISIN: IE000KD0BZ68
| Name | ISIN | Marktkapitalisierung | Gewichtung |
|---|---|---|---|
| Abbott Laboratories | US0028241000 | 216.027.554.535 € | 5,43 % |
| Natera Inc | US6323071042 | 21.394.661.309 € | 5,15 % |
| Roche Holding AG | CH0012032048 | 248.084.611.317 € | 5,05 % |
| Lonza Group Ltd | CH0013841017 | 43.539.608.673 € | 5,04 % |
| Agilent Technologies Inc | US00846U1016 | 36.903.176.426 € | 4,82 % |
| Thermo Fisher Scientific Inc | US8835561023 | 191.429.391.504 € | 4,72 % |
| Vertex Pharmaceuticals Inc | US92532F1003 | 113.533.295.063 € | 4,45 % |
| Bristol-Myers Squibb Co | US1101221083 | 105.678.339.074 € | 4,44 % |
| Danaher Corp | US2358511028 | 141.338.499.809 € | 4,11 % |
| IQVIA Holdings Inc | US46266C1053 | 32.542.766.935 € | 3,40 % |
| Summe Top 10 | 46,60 % | ||
Weitere ETFs mit gleicher Benchmark
| ETF | TER | Größe | Perf 1J |
|---|---|---|---|
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc | 0,30 % | 3,53 Mio. $ | - |
| iShares MSCI USA ESG Enhanced UCITS ETF USD Inc | 0,07 % | 19,76 Mrd. $ | +21,67 % |
| SPDR Bloomberg SASB U.S. Corporate ESG UCITS ETF | 0,15 % | 7,09 Mrd. $ | +4,73 % |
| Amundi Index Solutions - Amundi Index Euro Corporate SRI ETF DR Hedged USD Cap | 0,18 % | 6,55 Mrd. $ | +7,71 % |
| UBS(Lux)Fund Solutions – MSCI World Socially Responsible UCITS ETF(USD)A-acc | 0,20 % | 6,02 Mrd. $ | +14,06 % |